iRhythm EVP sells 2,585 shares in planned trade

iRhythm Holdings EVP Mervin Smith reported an open-market sale of 2,585 shares of common stock at $114.30 per share.

(Moderate)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

iRhythm Holdings EVP Mervin Smith reported an open-market sale of 2,585 shares of common stock at $114.30 per share. The transaction took place on March 16, 2026 and was executed under a pre-established Rule 10b5-1 trading plan adopted on November 19, 2025.

After this sale, Smith continues to hold 23,027 shares directly, indicating he retains a substantial equity position in the company despite the disposition.

Insider Trade Summary 10b5-1

Net Seller: 2,585 shares

Net Sell 1 txn

Insider Smith Mervin

Role EVP Strategic Business Ops

Sold 2,585 shs ($295K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,585	$114.30	$295K

Holdings After Transaction: Common Stock — 23,027 shares (Direct)

Footnotes (1)

F1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 19, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did iRhythm (IRTC) report for Mervin Smith?

iRhythm reported that EVP Strategic Business Ops Mervin Smith sold 2,585 shares of common stock. The sale occurred on March 16, 2026 at a price of $114.30 per share in an open-market transaction disclosed on Form 4.

How many iRhythm (IRTC) shares does Mervin Smith hold after this sale?

After the reported sale, Mervin Smith directly holds 23,027 shares of iRhythm common stock. This remaining stake shows he continues to have meaningful equity exposure to the company following the relatively small sale of 2,585 shares.

Was the iRhythm (IRTC) insider sale by Mervin Smith pre-planned?

Yes. The filing notes the sale was effected under a Rule 10b5-1 trading plan. That trading plan was established by Mervin Smith on November 19, 2025, indicating the transaction was pre-arranged rather than a discretionary market-timing decision.

What was the value of Mervin Smith’s iRhythm (IRTC) stock sale?

The transaction involved 2,585 shares sold at $114.30 per share. This implies gross sale proceeds of roughly $295,000 based on the disclosed per-share price, before any taxes, fees, or commissions associated with the open-market transaction.

What role does Mervin Smith hold at iRhythm (IRTC) in this Form 4?

In this Form 4, Mervin Smith is identified as an officer of iRhythm, serving as EVP Strategic Business Ops. His role as an executive makes his equity transactions subject to insider reporting requirements under U.S. securities regulations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/17/2026 - 04:31 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Mervin

(Last)

(First)

(Middle)

C/O IRHYTHM HOLDINGS, INC.

699 8TH STREET, #600

(Street)

SAN FRANCISCO

94103

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP Strategic Business Ops

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/16/2026	03/16/2026	S		2,585⁽¹⁾	D	$114.3	23,027	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 19, 2025.

Remarks:

	/s/ Marc Rosenbaum, attorney-in-fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR